Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 8-K, filed Aug 24, 2026
- Incorporated
- Delaware
- Filings on record
- 963 filings
- On EDGAR
- CIK 1133869
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 78
News 8 of 238
Prospectuses and Registrations 8 of 76
- S-8 Registration statement for an employee plan Jan 30, 2026
- 424B5 Prospectus supplement for an offering Dec 5, 2025
- 424B3 Prospectus supplement for an offering Dec 5, 2025
- 424B5 Prospectus supplement for an offering Dec 4, 2025
- S-3 Shelf registration statement Sep 10, 2025
- S-8 Registration statement for an employee plan Jun 16, 2025
- S-8 Registration statement for an employee plan Feb 5, 2025
- S-3 Shelf registration statement Oct 22, 2024
Proxies 8 of 24
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2026
- PRE 14A Preliminary proxy statement Mar 31, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2024
- PRE 14A Preliminary proxy statement Mar 20, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2023
- PRE 14A Preliminary proxy statement Apr 7, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 12, 2022
Ownership 8 of 406
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 19, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 3, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
Other 8 of 141
- ARS Annual report sent to shareholders Apr 10, 2026
- EFFECT Notice that a registration became effective Sep 23, 2025
- CORRESP Reply to SEC staff Sep 19, 2025
- UPLOAD Comment letter from SEC staff Sep 16, 2025
- ARS Annual report sent to shareholders Apr 9, 2025
- EFFECT Notice that a registration became effective Nov 8, 2024
- CORRESP Reply to SEC staff Nov 6, 2024
- UPLOAD Comment letter from SEC staff Oct 28, 2024
Everything here comes from Capricor Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.